ASH 2024: Changing the Treatment Landscape in Lymphoma
Research presented at ASH 2024 has shed new light on treatment strategies for mantle cell lymphoma and follicular lymphoma.
Related Articles
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapeutic treatment concept that is changing the treatment approach to hematologic malignancies. The development of CAR…
ASH 2024: Advances in CLL/SLL
Trial results presented at the ASH Annual Meeting 2024 could prompt changes in the treatment of CLL and SLL, experts say.
PreCancer Atlas Collection: From Biology to Cancer Interception | Cancer Prevention Research | American Association for Cancer Research
Developed to facilitate a better understanding across the prevention field of needed near-term next steps and long-term future directions to fully realize
Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis
Abstract. Adeno-associated virus (AAV)–based gene therapy is an emerging treatment for hemophilia A (HA) and hemophilia B (HB). In this systematic review a
Promising Advances in Hematology: Key Findings From ASH 2024
Here are some of the highlights from this year’s 2024 ASH Annual Meeting & Exposition.
FDA Accepts NDA for Avatrombopag in Pediatric Thrombocytopenia
Results from the phase 3 AVA-PED-301 trial support the FDA decision for avatrombopag in pediatric thrombocytopenia.
2025 FDA-AACR Workshop: DPD Deficiency and Weighing Potential Harms
AACR is hosting a workshop with the FDA on January 16, 2025, to discuss the considerations for routine testing of DPD deficiency before treatment with…
Optimizing antibody-drug conjugates with computational modelling
Melissa Calopiz, University of Michigan, Ann Arbor, MI, explores the use of SimADC, a computational model for designing and evaluating antibody-drug conjugates (ADCs). By simulating…
India Emerges as Global Pharma’s Capability Cntre Hub: A Look at the Driving Forces and Challenges
India is witnessing a surge in global pharmaceutical companies establishing and expanding their presence, with Hyderabad emerging as a key…
